Ultrasensitive digital immunoassays for SOD1 conformation in amyotrophic lateral sclerosis

Aim: The aim of this study was to detect misfolded Cu/Zn SOD1 as a potential biomarker for amyotrophic lateral sclerosis (ALS). Materials & methods: Two ultrasensitive immunodetection assays were developed for the quantification of total and misfolded SOD1. Results: The detection of total and misfolded SOD1 was possible in human serum and cerebrospinal fluid. Total SOD1 was increased in cerebrospinal fluid from ALS patients. Misfolded SOD1 had low and variable expression in both control and ALS patient samples. Conclusion: These assays hold promise for improving our understanding of ALS and its detection, and could lead to more effective treatment options in the future. Further studies in larger cohorts are now required.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Bioanalysis - 15(2023), 15 vom: 31. Aug., Seite 927-936

Sprache:

Englisch

Beteiligte Personen:

Morichon, Lisa [VerfasserIn]
Hirtz, Christophe [VerfasserIn]
Tiers, Laurent [VerfasserIn]
Mezghrani, Alexandre [VerfasserIn]
Raoul, Cédric [VerfasserIn]
Esselin, Florence [VerfasserIn]
La Cruz, Elisa De [VerfasserIn]
Julien, Jean-Pierre [VerfasserIn]
Camu, William [VerfasserIn]
Lehmann, Sylvain [VerfasserIn]

Links:

Volltext

Themen:

Amyotrophic lateral sclerosis
Cerebrospinal fluid
Conformational immunoassay
EC 1.15.1.1
Journal Article
SOD1 protein, human
Serum
Single molecule array
Superoxide Dismutase-1
Superoxide dismutase 1

Anmerkungen:

Date Completed 07.09.2023

Date Revised 07.09.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.4155/bio-2023-0103

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361483538